Startseite The crystal structure of 4-[(benzo[1,3]dioxol-5-ylmethylene)-amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one, C19H17N3O3
Artikel Open Access

The crystal structure of 4-[(benzo[1,3]dioxol-5-ylmethylene)-amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one, C19H17N3O3

  • Faisal M. S. Aqlan , Muhammad Nadeem Arshad EMAIL logo , Abdullah M. Asiri , Khalid A. Khan und Mohie E. M. Zayed
Veröffentlicht/Copyright: 24. August 2016

Abstract

C19H17N3O3, monoclinic, P21/a (no. 14), a = 7.1173(4) Å, b = 25.051(2) Å, c = 9.3822(8) Å, β = 100.484(6)°, V = 1644.9(2) Å3, Z = 4, Rgt(F) = 0.0571, wRref(F2) = 0.1457, T = 296 K.

CCDC no.:: 1474505

The crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Yellow blocks Size 0.44 × 0.27 × 0.11 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.9 cm−1
Diffractometer, scan mode:SuperNova, φ and ω
2θmax, completeness:59°, 85.3%
N(hkl)measured, N(hkl)unique, Rint:8775, 3897, 0.037
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2358
N(param)refined:226
Programs:SHELX [14], CrysAlisPRO [15]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.8310(3)0.35371(8)−0.0137(2)0.0374(5)
C20.7184(3)0.31565(9)0.0363(3)0.0459(6)
H20.71720.31270.13500.055*
C30.6075(4)0.28200(10)−0.0613(3)0.0606(7)
H30.52990.2567−0.02810.073*
C40.6110(4)0.28558(11)−0.2069(3)0.0653(8)
H40.53790.2624−0.27180.078*
C50.7225(4)0.32344(11)−0.2561(3)0.0642(8)
H50.72450.3259−0.35470.077*
C60.8324(3)0.35812(9)−0.1600(3)0.0485(6)
H60.90650.3841−0.19390.058*
C70.8580(3)0.42317(9)0.1772(2)0.0359(5)
C80.9856(3)0.46781(8)0.2054(2)0.0344(5)
C91.1320(3)0.45994(8)0.1306(2)0.0345(5)
C100.8267(3)0.51901(9)0.3510(2)0.0412(5)
H100.73690.49170.34400.049*
C110.8005(3)0.56652(9)0.4360(2)0.0377(5)
C120.6316(3)0.57225(9)0.4884(3)0.0456(6)
H120.53820.54600.46720.055*
C130.5974(3)0.61591(9)0.5715(3)0.0476(6)
H130.48510.61910.60840.057*
C140.7364(3)0.65355(9)0.5961(3)0.0423(5)
C150.9058(3)0.64867(9)0.5442(2)0.0406(5)
C160.9432(3)0.60544(9)0.4663(2)0.0410(5)
H161.05890.60190.43440.049*
C170.9063(4)0.72766(10)0.6527(3)0.0603(7)
H17A0.86960.75760.58820.072*
H17B0.97670.74120.74380.072*
C181.2537(3)0.38073(10)0.0136(3)0.0502(6)
H18A1.19830.3509−0.04320.075*
H18B1.32970.4012−0.04130.075*
H18C1.33290.36800.10080.075*
C191.3043(3)0.49301(10)0.1311(3)0.0470(6)
H19A1.30110.52330.19320.071*
H19B1.41640.47220.16600.071*
H19C1.30730.50500.03440.071*
N10.9411(2)0.38897(7)0.08763(19)0.0376(4)
N21.1016(2)0.41438(7)0.0507(2)0.0374(4)
N30.9689(2)0.51374(7)0.28597(19)0.0380(4)
O10.7026(2)0.41373(6)0.21339(18)0.0478(4)
O20.7409(2)0.69968(7)0.6766(2)0.0596(5)
O31.0221(2)0.69157(7)0.5897(2)0.0588(5)

Source of material

A mixture of 1,3-benzodioxole-5-carboxaldehyde (0.0033 mol, 0.5 g) and 4-amino-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one (0.0033 mol, 0.67 g) in absolute ethanol (20 mL) was refluxed at 353 K for 2 h with continuous stirring, while a few drops of acetic acid were added as catalyst. The reaction progress was monitored by TLC. On completion, the solution was cooled followed by filtration. The precipitate obtained was purified by recrystallization from ethanol.

Experimental details

All hydrogen atoms were positioned geometrically C—H = 0.93 Å and refined as riding model with Uiso = 1.2Ueq(C). The C—H distances for methyl and methelene were set to 0.96 Å and 0.97 Å and were also refined as riding atoms with Uiso = 1.5Ueq(C) and Uiso = 1.2Ueq(C) respectively.

Discussion

Pyrazole chemistry is well being explored due to their fascinating applications in pharmaceutical [1] and other industries [2, 3, 4]. Demands of supramolecular chemistry and metal-organic framework (MOF) applications [5] in various industries encourage the synthesis of novel ligands which have capabilities for complexation [6] with various metals. In this regard, pyrazole based molecules gained reasonable attention. Pyrazoles have found their applications in biological systems as analgesic [7], anti-inflammatory [8], antifungal [9], anti-hyperglycemic [10], antimicrobial [11], antitumor [12], antiviral [13] agents.

The central pyrazole ring (N1/N2/C9/C8/C7) in the crystal structure of title compound is highly crowded. A phenyl ring is present on N1, on the other hand N2 and C9 are flagged by methyl groups. C7 is functionalised by a carbonyl group and benzo[1,3]dioxol-5-ylmethylene)-amino group is available at C6. The pyrazole ring is almost planer with 0.0209 Å root mean square deviation of its fitted atoms, the most deviation was observed from N1 = −0.0392(1) Å and N2 = 0.0409(1) Å. C18 deviate more (r.m.s. −0.5556(4) Å) as compare to C19 (r.m.s. −0.1338(4) Å) to the plane produce through the fitted atoms of pyrazole ring. The ring system benzo[1,3]dioxole is not exactly planar as the dihedral angle between the benzene ring and dioxole ring is 2.14(2)°. The over all r.m.s. deviation of fitted atoms of benzo[1,3]dioxole is 0.0520 Å where the most deviations were observed from C17 −0.1204(2) Å and O2 −0.0688(2) Å. The pyrazole ring is oriented with a dihedral angle of 46.20(1)° and 8.72(1)° with respect to phenyl (C1-C6) and benzo[1,3]dioxole ring systems. The phenyl ring is oriented with a dihedral angle of 53.91(1) with respect to benzo[1,3]dioxole. Non-classical intermolecular hydrogen bonding interaction may be present (H⋯O = 2.46 Å) which connect the molecules to dimers and generating an eighteen membered ring motif. These dimers are further connected through C—H⋯O (D(H⋯O) = 2.48 Å), interactions to give an infinite chain along a.

Acknowledgements:

We acknowledge Center of Excellence for Advanced Materials Resaerch (CEAMR) and Chemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia, for their technical support.

References

1. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. F.; Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Veenhiuzen, A. W.; Zhang, Y. Y.; Isakson, P. C.: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. J. Med. Chem. 40 (1997) 1347–1365.10.1021/jm960803qSuche in Google Scholar

2. Jaunzems, J.; Braun, M.: An atom-efficient route to ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate (DFMMP)- A key building block for a novel fungicide family. Org. Process Res. Dev. 18 (2014) 1055–1059.10.1021/op500128pSuche in Google Scholar

3. Fustero, S.; Sánchez-Roselló, M.; Barrio, P.; Simón-Fuentes, A.: From 2000 to Mid-2010: a fruitful decade for the synthesis of pyrazoles. Chem. Rev. 111 (2011) 6984–7034.10.1021/cr2000459Suche in Google Scholar

4. Mandal, S.; Saha, R.; Saha, M.; Pradhan, R.; Butcher, R. J.; Saha, N. C.: Synthesis, crystal structure, spectral characterization and photoluminescence property of three Cd(II) complexes with a pyrazole based schiff-base ligand. J. Mol. Struct. 1110 (2016) 11–18.10.1016/j.molstruc.2016.01.020Suche in Google Scholar

5. Pettinari, C.; Tabacaru, A.; Galli, S.: Coordination polymers and metal-organic frameworks based on poly(pyrazole)-containing ligands. Coord. Chem. Rev. 307 (2016) 1–31.10.1016/j.ccr.2015.08.005Suche in Google Scholar

6. Davies, D. T.: Aromatic heterocyclic chemistry. Oxford University Press: Oxford, UK, 1992.Suche in Google Scholar

7. Menozzi, G.; Mosti, L.; Fossa, P.; Mattioli, F.; Ghia, M.: v-Dialkylaminoalkyl ethers of phenyl-(5-substituted 1-phenyl-1H-pyrazol-4-yl)methanols with analgesic and anti-inflammatory activity. J. Heterocycl. Chem. 34 (1997) 963–968.10.1002/jhet.5570340339Suche in Google Scholar

8. Alegaon, S. G.; Alagawadi, K. R.; Garg, M. K.; Dushyant, K.; Vinod, D.: 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents. Bioorg. Chem. 54 (2014) 51–59.10.1016/j.bioorg.2014.04.001Suche in Google Scholar

9. Sridhar, R.; Perumal, P. T.; Etti, S.; Shanmugam, G.; Ponnuswamy, M. N.; Prabavathy, V. R.; Mathivanan, N.: Design, synthesis and anti-microbial activity of 1H-pyrazole carboxylates. Bioorg. Med. Chem. Lett. 14 (2004) 6035–6040.10.1016/j.bmcl.2004.09.066Suche in Google Scholar

10. Bebernitz, G. R.; Argentieri, G.; Battle, B.; Brennan, C.; Balkan, B.; Burkey, B. F.; Eckhardt, M.; Gao, J.; Kapa, P.; Strohschein, R. J.; Schuster, H. F.; Wilson, M.; Xuet, D. D.: The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilization in ob/ob mice. J. Med. Chem. 44 (2001) 2601–2611.10.1021/jm010032cSuche in Google Scholar

11. Bekhit, A. A.; Fahmy, H. T. Y.; Rostom, S. A. F.; Baraka, A. M.: Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial agents. Eur. J. Med. Chem. 38 (2003) 27–36.10.1016/S0223-5234(02)00009-0Suche in Google Scholar

12. Manfredini, S.; Bazzanini, R.; Baraldi, P. G.; Bonora, M.; Marangoni, M.; Simoni, D.; Pani. A.; Scintu, F.; Pinna, E.; Pisano, L.; La Colla, P.: Pyrazole-related nucleosides. 4. Synthesis and antitumor activity of some 1-tetrahydropyranyl-4-substituted pyrazoles. Anti-cancer Drug Des. 11 (1996) 193–204.Suche in Google Scholar

13. El-Sabbagh, O. I.; Baraka, M. M.; Ibrahim, S. M.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Rashad, A. A.: Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur. J. Med. Chem. 44 (2009) 3746–3753.10.1016/j.ejmech.2009.03.038Suche in Google Scholar PubMed

14. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

15. Agilent Technologies: CrysAlisPRO Software system, version 1.171.35.15. Agilent Technologies UK Ltd, Oxford, UK, 2011.Suche in Google Scholar

Received: 2016-4-16
Accepted: 2016-8-1
Published Online: 2016-8-24
Published in Print: 2016-12-1

©2016 Faisal M. S. Aqlan et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of the catena-poly-[bis(μ2-1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl-κN)-1,4-dihydroquinoline-3-carboxylato-κ2O,O′)nickel(II)] 5.5 hydrate, C32H44N6NiO11F2
  3. Crystal structure of catena-poly-[(μ2-2-(2-((2,6-dimethylphenyl)amino)phenyl)acetato-κ2O:O′)(μ2-2-(2-((2,6-dimethylphenyl)amino)phenyl)acetate-κ3O,O′:O′)cadmium(II)], C28H20N2Cl4O4Cd
  4. Crystal structure of catena-poly[dichlorido-(μ2-4-(pyridin-4-yl)-isophthalate-κ2O, O′)cadmium(II)] monohydrate, C13H11NO5Cl2Cd
  5. Crystal structure of poly-{[μ2-(E)-1,4-di(1H-imidazol-1-yl)but-2-ene-κ2N:N′][μ2-cyclohexane-1,4-dicarboxylato-κ4O,O′:O′′,O′′′]nickel(II)}, C18H22N4NiO4
  6. Crystal structure of aqua (5,5′-dicarboxy-(1,1′-biphenyl)-2,3′-dicarboxylato-κO) bis(1,10-phenanthroline-κ2N,N′)cadmium monohydrate, C40H28CdN4O10
  7. Crystal structure of 5-methoxy-N′-[(3Z)-5-chloro-1-(4-fluorobenzyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-1H-indole-2-carbohydrazide-DMSO (1/1), C25H18ClFN4O3 · C2H6OS
  8. Crystal structure of 5-methoxy-N′-[(3Z)-1-benzyl-5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-1H-indole-2-carbohydrazide-DMSO (1/1), C27H25FN4O4S
  9. Crystal structure of poly-[bis{μ2-N-(4-(1H-imidazol-1-yl)phenyl)-4-(1H-imidazol-1-yl)-N-phenylaniline-κ2N:N′)}-(μ2-naphthalene-2,6-dicarboxylato)-(μ4-naphthalene-2,6-dicarboxylato)dicadmium(II)], C36H25N5O4Cd
  10. Crystal structure of 1-(adamantan-1-yl)-3-(4-bromophenyl)thiourea, C17H21BrN2S
  11. Crystal structure of N′-[(1E)-(2,6-dichlorophenyl)-methylidene]adamantane-1-carbohydrazide, C18H20Cl2N2O
  12. Crystal structure of dichlorido{bis(2-hydroxyethyl)-5′-([2,2′:6′,2′′-terpyridin]-4′-yl)-[1,1′:3′,1′′-terphenyl]-4,4′′-dicarboxylate-κ3N,N′,N′′}zinc(II), C39H31Cl2N3O6Zn
  13. Crystal structure of 4,4′-(1,3,5,7-tetraoxo-3a,4,4a,5,7,7a,8,8a-octahydro-4,8-ethenopyrrolo [3,4-f]isoindole-2,6(1H,3H)-diyl)dibenzoic acid, C26H18N2O8
  14. Crystal structure of (E)-1-(4-(((E)-3,5-dichloro-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-ethyl oxime, C17H16Cl2N2O2
  15. The crystal structure of diaqua-(N-(2-hydroxy-5-nitrobenzyl)iminodiacetato-κ4-N,O,O′,O′′)chromium(III) based on synchrotron data, C11H13CrN2O9
  16. Crystal structure of ethyl 5-amino-3-(methylthio)-1-(1-phenyl-5-(thiophen-2-yl)-1H-pyrazole-3-carbonyl)-1H-pyrazole-4-carboxylate, C21H19N5O3S2
  17. Crystal structure of (E)-1-(4-(((E)-3,5-dibromo-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-methyl oxime, C17H16Br2N2O2
  18. Crystal structure of dibromido μ-oxalato-κ2O,O′:κ2O′′,O′′′−η6-p-cymenediosmium(II), C22H28Br2O4Os2
  19. Crystal structure of 2-(bromomethyl)-4-(4-chlorophenyl)-1-tosylpyrrolidine, C18H19BrClNO2S2
  20. Crystal structure of 5-(3-fluorobenzylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione; C13H11FN2O3
  21. Crystal structure of diethylammonium 1,3-dimethyl-2,4,6-trioxohexahydropyrimidin-5-ide, C10H19N3O3
  22. Crystal structure of 1,1-dimethyl-3-(2-phenylethyl)urea, C11H16N2O
  23. Crystal structure of 2-(4-methoxyphenyl)-1,3-thiazolo[4,5-b]pyridine, C13H10N2OS
  24. Crystal structure of 3-tert-butyl-7-azadioxindole, C11H14N2O2
  25. Crystal structure of 1-ferrocenyl-6-bromopyrene, C26H17BrFe
  26. Crystal structure of 3-(4-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide, C16H13BrFN3S
  27. Crystal structure of 2-amino-4-(3,5-ditrifluoromethylphenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C20H16F6N2O2
  28. The crystal structure of 2-amino-4-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13N3O4
  29. Crystal structure of 2-amino-4-(2, 4-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  30. Crystal structure of bis(μ2-chlorido)-bis(di-p-tolylhydroxyphosphine-κP)-bis(di-p-tolylphosphite-κP)dipalladium(II), C56H58Cl2O4P4Pd2
  31. Crystal structure of diaqua-bis(2-methyl-1H-imidazole-4,5-dicarboxylato-κ2-O,N)cadmium(II) tetrahydrate, C12H22CdN4O14
  32. Crystal structure of aqua-(5-nitrosalicylato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)copper(II), C19H13CuN3O6
  33. Crystal structure of bis(4-(2-phenylpropan-2-yl)phenyl)amine, C30H31N
  34. Crystal structure of 2-amino-4-(3,5-difluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H16F2N2O2
  35. Crystal structure of 2-amino-4-(3,4,5-trifluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H11F3N2O2
  36. Crystal structure of an isomeric bis[(η5:η1-6,6-di-p-tolylpentafulvene)(η5-pentamethylcyclopentadienyl)titanium(III)]-μ2,η1:η1-dinitrogen complex, C60H66N2Ti2
  37. Crystal structure of 3,4-dinitropyrazole, C3H2N4O4
  38. Crystal structure of (4-vinylpyridine-κN)triphenyl tin(IV) chloride, C25H22ClNSn
  39. Crystal structure of tert-butyl 2-phenylethylcarbamate, C13H19NO2
  40. Crystal structure of (Z)-4-((E)-(4-chlorobenzyli-dene)hydrazono)-1-p-tolylpyrrolidine-3-carbonitrile, C19H17ClN4
  41. Crystal structure of bis(biphenyl-2,2′-dicarboxylato-κ2O:O′)-bis(1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylato-κ2O,O′)dizinc(II)2.5 hydrate, C62H57N6Zn2O16.5F2
  42. Crystal structure of dichloridobis{μ2-2,2′-((1E,1′E)-(ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(4-chlorophenolato)-κ5O,N,N′,O′:O′}diiron(III), C32H24Cl6Fe2N4O4
  43. Crystal structure of 4-((4,4-dimethyl-2, 6-dioxocyclohexylidine)methylamino)-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide, C20H23N3O5S
  44. Crystal structure of poly-[aqua-μ2-aqua-μ2-(4,4′-oxybis(benzoato)-κ4O,O′:O′′,O′′′)cadmium(II)], C14H12O7Cd
  45. Crystal structure of aqua(μ2-biphenyl-2,2′-dicarboxylato-κ3O,O′:O′′)-(μ2-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylato-κ2O,O′)cadmium(II) 1.5 hydrate, C62H60N6Cd2O19F2
  46. Crystal structure of dimethanolo-bis[μ-(2-(2-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)phenoxy)benzoato)-κ5O,O′,N:N′,N′′]dicopper(II) — methanol (1/2), C46H48Cu2N8O12
  47. Crystal structure of poly-[tetraaqua-bis(μ4-2,5-dibenzoyl-1,4-benzenedicarboxylato-κ4O1:O2:O3:O4)-μ2-2,5-dibenzoyl-1,4-benzenedicarboxylato-k4O5,O6: O5′,O6′-didysprosium(III)] tetrahydrate C33H26O13Dy
  48. Crystal structure of hexaaqua-bis(3-(3-pyridin-4-yl-[1,2,4]oxadiazol-5-yl) propionato-κ3O,O′:O′)-bis(3-(3-pyridin-4-yl-[1,2,4]oxadiazol-5-yl)propionato-κO)-bis(3-(3-pyridin-4-yl-[1,2,4]oxadiazol-5-yl)propionato-κ2O,O′)dineodymium(III) octahydrate, C60H76N18O32Nd2
  49. Crystal structure of poly-[triaqua-(μ3-3,4,5,6-tetrafluoro-1,2-phthalato-κ4O:O′:O′′,O′′′) (2,3,4,5-tetrafluoro-benzoato-κ2O,O′) praseodymium(III)], C15H7F8O9Pr
  50. The crystal structure of dichlorido (1,3-dimesityl-1H-3λ4-imidazol-2-yl)(isoquinoline-κN)palladium(IV) – ethylacetate (1/1), C34H39Cl2N3O2Pd
  51. Crystal structure of dichlorido(1,3-bis(2,6-dimethyl-phenyl)-1H-3λ4-imidazol-2-yl)(isoquinolinyl)palladium(IV), C28H27Cl2N3Pd
  52. Crystal structure of 5-(4-(1H-tetrazol-5-yl)phenyl)-1H-imidazol-3-ium 7-carboxy-1,3-dioxo-1H,3H-benzo[de]isochromene-6-carboxylate monohydrate 4,5-anhydride, C24H16N6O8
  53. Crystal structure of poly-[diaqua-bis(μ2-2-((1H-1,2,4-triazol-5-yl)thio)acetato-κ2N:O) cadmium(II)], C8H8CdN6O6S2
  54. Crystal Structure of (E)-3-(4-methoxyphenyl)-1-(2,3,4-tris(benzyloxy)-6-hydroxyphenyl)prop-2-en-1-one, C37H32O6
  55. Structure and photochromism of 1-(1,2-dimethylindol-3-yl)-2-[2-methyl-5-(3-fluorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C26H18F7NS
  56. Crystal structure of two-dimensional coordination polymer poly-[μ2-azido-aqua-(μ2-pyrazine-2-carboxylato-κ3O,N:N′)nickel(II)], C5H5N5O3Ni
  57. Crystal structure of 2-amino-5-oxo-4-(3,5-bis(trifluoromethyl)phenyl)-4H,5H-pyrano [3,2-c]chromene-3-carbonitrile, C21H10F6N2O3
  58. Crystal structure of 4-(5-((2-methylbenzyl)thio)-4-phenyl-4H-1,2,4-triazol-3-yl)pyridine, C21H18N4S
  59. Crystal structure of 5-(2-chloro-5-nitrophenyl)-3-(4-chlorophenyl)-N-ethyl-4,5-dihydro-1H-pyrazole-1-carbothioamide, C18H16Cl2N4O2S
  60. Crystal structure of 4-(benzofuran-2-yl)-2-(3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2H-benzo[g]indazol-2-yl)thiazole, C28H20FN3OS
  61. Crystal structure of bis(dicyanamido-κ1N)-tetrakis[1-benzyl-1H-1,2,4-triazole-κ1N]cobalt(II), CoC40H36N18
  62. Crystal structure of 1-benzyl-6-hydroxy-1,4,5,6-tetrahydropyridine-3-carbonitrile, C13H14N2O
  63. Crystal structure of 2-amino-7-methyl-4-(3,4-difluoro-phenyl)-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H10F2N2O3
  64. The crystal structure of 4-[(benzo[1,3]dioxol-5-ylmethylene)-amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one, C19H17N3O3
  65. Crystal structure of 1,4-dihydro-1-phenylchromeno[4,3-c]pyrazole, C16H12N2O
  66. Crystal structure of N-(5-((3,5-dimethylisoxazol-4-yl)sulfonyl)quinolin-8-yl)benzamide, C21H17N3O4S
  67. Crystal structure of 3-amino-9-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
  68. Crystal structure of 1,2-bis(4-methoxyphenyl)-2-((3-(trifluoromethyl)phenyl)amino)ethan-1-one, C23H20F3NO3
  69. Crystal structure of 2-amino-4-(2,4-dinitrophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile – ethanol (1:1), C21H16N4O8
  70. Crystal structure of catena-poly-[(1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate-κ2O,O′)-(μ2-4,4′-sulfonyldibenzoato-κ4O,O′:O′′,O′′′)zinc(II)] hemihydrate, C31H27ZnFN3O9.5S
  71. Crystal structure of 2-(2-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylic acid, C12H13BrO4
  72. Crystal structure of 2-(2-bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylic acid, C13H15BrO4
  73. Crystal structure of 4-(4-((3-bromophenyl)amino)-6-(tert-butyl)-3-(2-hydroxypropan-2-yl)cinnolin-8-yl)-2-methylbut-3-yn-2-ol, C26H30BrN3O2
  74. Crystal structure poly-(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazolyl-κ2NN1:N2N)-(μ3-2,2′-(1,2-phenylene)diacetato-κ5-O1,O2:O2:O3,O4)cadmium(II), C22H19CdN5O4
  75. Crystal structure of bis(1-ethyl-6-fluoro-4-oxido-7-(piperazin-1-ium-1-yl)-1,8-naphthyridin-1-ium-3-carboxylate-κ2O,O′)copper(II) benzene-1, 4-dicarboxylate dihydrate, C38H42F2CuN8O12
  76. Redetermination of the crystal structure of potassium lithium molybdate monohydrate, KLiMoO4·H2O
  77. Crystal structure of [tris(2-benzimidazolylmethyl)amine-κ3N](isonicotinate-κO) cobalt(II) [tris(2-benzimidazolylmethyl)amine-κ3N](isonicotinic acid-κO) cobalt(II) triperchlorate, C60H51N16O16Cl3Co2
  78. The crystal structure of tris(μ2-1,3-bis(4,4,4-trifluoro-3-oxido-1-(oxo)but-2-en-1-yl)phenyl-κ4O,O′:O′′,O′′′)-bis(1,2-dimethoxyethane-κ2O,O′)dicerium(III), C50H38F18O16Ce2
  79. Crystal structure of 8-isopropyl-8-aza-bicyclo[3.2.1]octan-3-ol, C10H19NO
  80. Crystal structure of 2,4-dibenzoyl-N,N-dimethylbenzenamine, C22H19NO2
  81. The crystal structure of 2-(4-methoxyphenyl)-6,8-diphenyl-4-(phenylamino)quinazoline — acetonitrile (1/1), C35H28N4O
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0125/html
Button zum nach oben scrollen